The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts-Reference-Cited by-同舟云学术

The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts

Published:2015-12 Issue:1 Volume:369 Page:229-241
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Strecker Tracy E.,Odutola Samuel O.,Lopez Ramona,Cooper Morgan S.,Tidmore Justin K.,Charlton-Sevcik Amanda K.,Li Li,MacDonough Matthew T.,Hadimani Mallinath B.,Ghatak Anjan,Liu Li,Chaplin David J.,Mason Ralph P.,Pinney Kevin G.,Trawick Mary Lynn^ORCID

Funder

National Cancer Institute

OXiGENE, Inc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. The tumor vascular targeting agent combretastatin A–4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells;Kanthou;Blood,2002

2. A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment;Mason;Integr. Biol,2011

3. Vascular targeted therapies in oncology;Siemann;Cell Tissue Res,2009

4. Tumour vasculature as a target for cancer therapy;Chaplin;Br. J. Cancer,1999

5. Disrupting tumour blood vessels;Tozer;Nat. Rev. Cancer,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute vasculature disruption in orthotopic kidney tumors based on vascular disrupting agent (OXi8007) examined by multispectral optoacoustic tomography (MSOT);Photons Plus Ultrasound: Imaging and Sensing 2024;2024-03-12

2. Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization;European Journal of Medicinal Chemistry;2024-01

3. Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues;Bioorganic & Medicinal Chemistry;2023-09

4. Synthesis of the Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor, 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977, Belzutifan); Efficient Replication of Established Approaches;Tetrahedron Letters;2023-09

5. SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis;Cancer Letters;2023-02